Systematic review of 139 RCTs of heart failure drugs (292,027 patients, 28.1% women; 78 meta-analysed): no sex difference in effect on the primary outcome (delta ln[REM] 0.00), and the share of women enrolled was not linked to effect size.
Meta-analysisn = 292,027
van der Bijl et al. Sex differences in pharmacological treatment of heart failure: a meta-analysis of randomized trials